表紙:H1N1ワクチンの世界市場:業界動向、市場シェア・規模・成長率・機会および予測(2021年~2026年)
市場調査レポート
商品コード
999709

H1N1ワクチンの世界市場:業界動向、市場シェア・規模・成長率・機会および予測(2021年~2026年)

H1N1 Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

出版日: | 発行: IMARC Services Private Limited | ページ情報: 英文 111 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.77円
H1N1ワクチンの世界市場:業界動向、市場シェア・規模・成長率・機会および予測(2021年~2026年)
出版日: 2021年05月20日
発行: IMARC Services Private Limited
ページ情報: 英文 111 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のH1N1ワクチンの市場規模は、2020年に18億米ドルの価値に達しました。H1N1ウイルスは、持続性の咳、高熱、赤い涙目、体の痛み、頭痛を特徴とする感染症です。この病気は、肺炎、慢性閉塞性肺疾患(COPD)、気管支炎などの既存の慢性疾患に悪影響を与えることが知られており、重症の場合は致命的となる可能性があります。 H1N1ワクチンは、ウイルスに対する能動免疫を提供するために皮内および鼻腔内処置を通じて投与される予防措置です。

流行性H1N1感染の発生率の増加と一般の人々の免疫力の低下が、市場成長を促進する主要な要因となっています。加齢とともに、気道疾患や免疫不全障害を発症するリスクも高まり、それによってH1N1インフルエンザ感染のリスクが高まります。しかし、免疫学およびワクチン技術の分野における広範な研究開発と、世界の保健機関からの広範な支援が相まって、高品質のワクチンの流通を促進することが期待されています。また、オーストラリア、英国、米国などの先進国は、これらのワクチンの需要が増加している全国予防接種プログラム(NIP)の下でH1N1の予防接種を組み込んでいます。さらに、予防法に関する患者の意識の高まりと相まって、技術進歩もH1N1ワクチン需要の上昇につながっています。世界のH1N1ワクチン市場は、今後5年間で緩やかに成長すると予想されています。

当レポートは世界のH1N1ワクチン市場について調査しており、業界動向、市場予測、ワクチンタイプ・タイプ・主要ブランド・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 序文

第2章 範囲と調査方法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界のH1N1ワクチン市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • ワクチンタイプ別の内訳
  • タイプ別の内訳
  • 主要ブランドの分析
  • 地域別の内訳

第6章 ワクチンタイプ別市場セグメンテーション

  • 筋肉内
  • 鼻腔内
  • 皮内

第7章 タイプ別の市場セグメンテーション

  • 公共
  • 民間

第8章 地域別の市場セグメンテーション

  • 北米
  • 欧州
  • アジア太平洋地域
  • 中東・アフリカ
  • ラテンアメリカ

第9章 主要ブランドの分析

  • アグリパル
  • Fiuarix
  • インフルゲン
  • Influvac
  • Nasovac
  • Vaxigrip
  • その他

第10章 SWOT分析

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

第13章 価格分析

  • 価格指標
  • 価格構造
  • マージン分析

第14章 業界動向

  • パイプラインと新製品の発売
  • 合併・買収およびパートナーシップ

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
図表

List of Figures

  • Figure 1: Global: H1N1 Vaccines Market: Major Drivers and Challenges
  • Figure 2: Global: H1N1 Vaccines Market: Sales Value (in Billion US$), 2015 - 2020
  • Figure 3: Global: H1N1 Vaccines Market: Breakup by Vaccines Type (in %), 2020
  • Figure 4: Global: H1N1 Vaccines Market: Breakup by Type (in %), 2020
  • Figure 5: Global: H1N1 Vaccines Market: Breakup by Region (in %), 2020
  • Figure 6: Global: H1N1 Vaccines Industry: SWOT Analysis
  • Figure 7: Global: H1N1 Vaccines Industry: Value Chain Analysis
  • Figure 8: Global: H1N1 Vaccines Industry: Porter's Five Forces Analysis
  • Figure 9: Global: H1N1 Vaccines Market Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 10: Global: H1N1 Vaccines (Intramuscular) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 11: Global: H1N1 Vaccines (Intramuscular) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 12: Global: H1N1 Vaccines (Intranasal) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 13: Global: H1N1 Vaccines (Intranasal) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 14: Global: H1N1 Vaccines (Intradermal) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 15: Global: H1 N1 Vaccines (Intradermal) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 16: Global: H1N1 Vaccines (Public) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 17: Global: H1N1 Vaccines (Public) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 18: Global: H1N1 Vaccines (Private) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 19: Global: H1N1 Vaccines (Private) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 20: North America: H1N1 Vaccines Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 21: North America: H1N1 Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 22: Europe: H1N1 Vaccines Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 23: Europe: H1N1 Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 24: Asia Pacific: H1N1 Vaccines Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 25: Asia Pacific: H1N1 Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 26: Middle East and Africa: H1N1 Vaccines Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 27: Middle East and Africa: H1N1 Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 28: Latin America: H1N1 Vaccines Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 29: Latin America: H1N1 Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026

List of Tables

  • Table 1: Global: H1N1 Vaccines Market: Key Industry Highlights, 2020 and 2026
  • Table 2: Global: H1N1 Vaccines Market Forecast: Breakup by Vaccines Type (in Million US$), 2021-2026
  • Table 3: Global: H1N1 Vaccines Market Forecast: Breakup by Type (in Million US$), 2021-2026
  • Table 4: Global: H1N1 Vaccines Market Forecast: Breakup by Region (in Million US$), 2021-2026
  • Table 5: Global: H1N1 Vaccines Market Structure
  • Table 6: Global: H1N1 Vaccines Market: Key Players
目次
Product Code: SR1020C75_Report

The global H1N1 vaccines market reached a value of US$ 1.8 Billion in 2020. Looking forward, IMARC Group expects the market to exhibit moderate growth during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end-use sectors. These insights are included in the report as a major market contributor.

The H1N1 virus is an infectious disease characterized by a persistent cough, high fever, red-watery eyes, body aches and headache. The illness is known to have a detrimental effect on the existing chronic ailments, such as Pneumonia, Chronic Obstructive Pulmonary Disease (COPD) and Bronchitis, and can be fatal in severe cases. H1N1 vaccines are a preventive measure administered through intradermal and intranasal procedures to provide active immunization against the virus.

Increasing incidences of epidemic H1N1 infection and declining immunity of the general population are among the key factors driving the market growth. With increasing age, the risk of developing respiratory tract diseases and immunodeficiency disorders also escalates, thereby increasing the risk of acquiring the H1N1 flu infection. However, extensive research and development in the field of immunology and vaccine technologies coupled with extensive support from global health organizations are expected to promote the distribution of quality vaccines. Moreover, a number of developed countries such as Australia, the United Kingdom, and the United States have also included H1N1 vaccinations under their National Immunization Program (NIP) that has increased the demand for these vaccines. Additionally, technological advancements coupled with a rising awareness amongst patients about preventive methods has also led to a heightened demand for H1N1 vaccines.

IMARC Group's latest report provides a deep insight into the global H1N1 vaccines market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the global H1N1 vaccines industry in any manner.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global H1N1 vaccines market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, vaccine type, key brands and market type.
  • Breakup by Vaccine Type
  • Intramuscular
  • Intranasal
  • Intradermal

Breakup by Market Type:

  • Public
  • Private

Analysis of Key Brands:

  • Agripal
  • Fiuarix
  • Influgen
  • Influvac
  • Nasovac
  • Vaxigrip
  • Others

Breakup by Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Competitive Landscape:

  • The report has also analysed the competitive landscape of the market along with the profiles of the key players.

Key Questions Answered in This Report:

  • How has the global H1N1 vaccines market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global H1N1 vaccines industry?
  • What are the popular vaccines type?
  • What are the major market types?
  • What are the various stages in the value chain of the global H1N1 vaccines industry?
  • What are the key driving factors and challenges in the global H1N1 vaccines market?
  • What is the structure of the global H1N1 vaccines industry and who are the key players?
  • What is the degree of competition in the industry?
  • What are the profit margins in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global H1N1 Vaccines Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Breakup by Vaccines Type
  • 5.5 Breakup by Market Type
  • 5.6 Analysis of Key Brands
  • 5.7 Breakup by Region
  • 5.8 Market Forecast

6 Market Breakup by Vaccines Type

  • 6.1 Intramuscular
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Intranasal
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Intradermal
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Type

  • 7.1 Public
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Private
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Europe
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Asia Pacific
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Middle East and Africa
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Latin America
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Analysis of Key Brand

  • 9.1 Agripal
  • 9.2 Fiuarix
  • 9.3 Influgen
  • 9.4 Influvac
  • 9.5 Nasovac
  • 9.6 Vaxigrip
  • 9.7 Others

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

  • 13.1 Price Indicators
  • 13.2 Price Structure
  • 13.3 Margin Analysis

14 Industry Developments

  • 14.1 Pipeline and New Product Launches
  • 14.2 Mergers & Acquisitions and Partnerships

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players